Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence

Risks of SARS-CoV-2 Infection and Immune Response to COVID-19 Vaccines in Patients With Inflammatory Bowel Disease: Current Evidence

Inflammatory bowel diseases (IBD), including Crohn’s disease, ulcerative colitis, and unclassified inflammatory bowel disease, are a group of chronic, immune mediated conditions that are presumed to occur in genetically susceptible individuals because of a dysregulated intestinal immune response to...

Full description

Bibliographic Details
Main Authors: Susanna Esposito, Caterina Caminiti, Rosanna Giordano, Alberto Argentiero, Greta Ramundo, Nicola Principi
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Immunology
Subjects:
COVID-19
COVID-19 vaccine
Crohn’s disease
inflammatory bowel diseases
SARS-CoV-2
ulcerative colitis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.933774/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.933774/full

Similar Items